Loading company…
Suzhou Qide Pharmaceutical Technology develops biopharmaceutical products and bio-conjugated drugs, including ADC therapies for tumors.
Suzhou Qide Pharmaceutical Technology Co., Ltd. develops biopharmaceutical and biotechnology products, reagents and other health-related products, with a focus on innovative therapies for tumors and other diseases, including ADC drugs. Founded in 2013 and based in Suzhou, China, the company raised an undisclosed amount of Series B funding in May 2021, led by a new investor with Win Digital Investment Management, HighLight Capital and BrightGene Bio-Medical Technology Co., Ltd. It is at the Series C stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in